---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-098228"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2024-09-09T23:59:59+00:00"
generated_at: "2026-05-31T05:55:54.039023+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers closes MedisourceRx acquisition; registers 976K shares for resale

## Summary
- Acquisition of Seaview Enterprises LLC (MedisourceRx) closed on September 5, 2024.
- 976,341 shares of Class A common stock issued to Nivagen Pharmaceuticals as part of consideration.
- Prospectus supplement filed on September 9, 2024 to register resale of those shares.
- Purchase agreement was originally entered on July 5, 2024.

## SEC filing metadata
- accession: 0001104659-24-098228
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2024-09-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/0001104659-24-098228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000110465924098228/tm2422489d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-098228
- JSON: https://secwatch.observer/filing/0001104659-24-098228.json
- Plain text: https://secwatch.observer/filing/0001104659-24-098228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.